Briefing

Tracking GLP-1 prescribing trends

GLP-1s have recently soared in popularity as new weight loss alternatives. Originally created to treat diabetes, these drugs – including Ozempic, Wegovy, and Mounjaro – have been found to suppress appetites and induce substantial weight loss in many patients. Extensive media coverage and celebrity endorsements have only heightened demand. Using real-time data, Truveta analyzed trends in first-time GLP-1 prescriptions.

Download the briefing for insight into:

  • The demographic characteristics of patients being prescribed GLP-1s for the first time
  • First-time GLP-1 prescribing volumes by medication and by brand
  • The frequency of off label cosmetic use
Tracking GLP-1 prescribing trends

Read the briefing now